Variant position: 144 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 699 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human RLKYLSICNTGIRKFPDVTK VFSSESNFILEICDNLHITTI
Mouse RLKYLSICNTGIRTLPDVSK ISSSEFNFILEICDNLYITTI
Rat RLKYLSICNTGIRTLPDVTK ISSSEFNFILEICDNLHITTI
Pig RLKYLSICNTGIRKLPDVTK IFSSEFNFILEICDNLHITTV
Bovine RLKYLSICNTGIHKLPDVTK IFSSEFNFILEICDNLHITTI
Chicken RLKYLSICNTGIIEFPDLTQ IFSSEAHFILELCDNLRMTTI
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
27 – 699 Lutropin-choriogonadotropic hormone receptor
27 – 363 Extracellular
124 – 145 LRR 2
Leydig cell hypoplasia: absent luteinizing hormone receptor cell surface expression caused by a novel homozygous mutation in the extracellular domain.
Richter-Unruh A.; Verhoef-Post M.; Malak S.; Homoki J.; Hauffa B.P.; Themmen A.P.N.;
J. Clin. Endocrinol. Metab. 89:5161-5167(2004)
Cited for: VARIANT LHR PHE-144; CHARACTERIZATION OF VARIANT LCH PHE-144;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.